JMP Securities Downgrades Aclaris Therapeutis (ACRS) to Market Perform
Tweet Send to a Friend
JMP Securities analyst Donald Ellis downgraded Aclaris Therapeutis (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
